POET Technologies Rallies on Capacity Scramble as Legal and Dilution Concerns Weigh
Published on 07/21/2026 at 18:07 | Redaktion boerse-global.de
Investors piled into POET Technologies on Tuesday after reports surfaced that the company had stopped accepting new customer orders for the next twelve months, with manufacturing capacity already spoken for. The stock vaulted 11.5% to €7.27, recouping some of the heavy losses that have piled up since a devastating order cancellation in late April. The capacity crunch is being interpreted as a powerful signal that demand for POET’s optical interposer technology — used in artificial intelligence and data centre gear — is outstripping supply just as the company prepares to transition from development to volume production.
The rally comes against a backdrop of serious headwinds. In late April, shares plunged 47.3% in a single session after Marvell Semiconductor, which had taken over Celestial AI, tore up all its purchase orders, citing an alleged breach of confidentiality by POET management. The incident triggered a class action lawsuit filed by Levi & Korsinsky on behalf of investors who bought POET stock between April 1 and April 27, 2026. The complaint also accuses the company of making false statements about its PFIC tax status and business relationships. With the lead plaintiff deadline past on June 29, the legal overhang remains a persistent concern.
Compounding the legal uncertainty is a dramatic dilution story. According to the lawsuit filing, POET has generated only $2.3 million in cumulative revenue since 2020 while its share count surged 303% from 38 million to 153 million between end-2022 and early 2026. In May, the company raised $400 million through a placement of 19 million new shares at $21 each, accompanied by three-year warrants exercisable at $26.15. That deal was part of a wider $830 million equity raising effort over the past twelve months, including a single $400 million institutional investment at $21 per share. CFO Thomas Mika also announced his retirement after a decade in the role, sending the stock down more than 15% in a single day.
Should investors sell immediately? Or is it worth buying POET Technologies?
Institutional sentiment has been decidedly mixed. Private Advisor Group LLC slashed its holding by 96.4% in the first quarter, selling 412,246 shares and leaving a residual position of just 15,450 shares worth $92,000. Wall Street Zen has downgraded POET to “Sell,” while Weiss Ratings maintained its sell recommendation. The consensus analyst price target stands at $8.00. On the other hand, some funds have trickled in: Advisory Services Network built a $25,000 stake, Quarry LP entered with $29,000, and Albion Financial Group boosted its holding by 233.3% to 10,000 shares. Still, total institutional ownership sits at a mere 1.99% of outstanding shares, underscoring widespread caution.
The company is leaning heavily on a partnership with Lumilens to turn the tide. An initial order worth $50 million for optical engines is already booked, and the underlying framework agreement envisions cumulative revenues of up to $500 million over five years — contingent on POET hitting specified development and qualification milestones. Management has reaffirmed that the production ramp for optical engines will begin in the second half of 2026, backed by a $50 million investment in new equipment over the coming months. The longer-term target is to expand capacity to one million units per month by the end of 2027, more than ten times current levels.
For all the optimism around the capacity crunch, the stock remains more than 61% below its 52-week high of €18.84 reached in May 2026. Tuesday’s surge shows that some investors are betting the order book constraint signals genuine product demand rather than a temporary bottleneck. Yet with a class action suit in play, a massively diluted share count, and institutional wariness still high, the path to sustained recovery will require POET to translate its manufacturing ambitions into tangible revenue — starting with the production numbers due in the second half of the year.
Ad
POET Technologies Stock: New Analysis - 21 July
Fresh POET Technologies information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
